News Release 

Aspirin use after biliary tract cancer diagnosis

JAMA Oncology

What The Study Did: Researchers in this observational study examined if aspirin use after a diagnosis of a biliary tract cancer, which includes gallbladder cancer, was associated with reduced risk of death among nearly 3,000 patients.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

Authors: Sarah S. Jackson, Ph.D., of the National Cancer Institute in Rockville, Maryland, is the corresponding author.

(doi:10.1001/jamaoncol.2019.4328)

Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2019.4328?guestAccessKey=4b431465-c9dc-4248-b994-80f4c972fac7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101719

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.